Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Hepatology
Institutions: Indiana University School of Medicine, University of Virginia, Rutgers, The State University of New Jersey, Rutgers New Jersey Medical School, Einstein Healthcare Network, University of Miami, Hospital of the University of Pennsylvania, California Liver Research Institute, Ohio Gastroenterology and Liver Institute, Indiana University Hospital
Language: English
Topic: Liver Diseases and Immunity
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3196850442
